Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 20Carcinoma, Hepatocellular 8Stomach Neoplasms 6Multiple Myeloma 6Colorectal Neoplasms 6Uterine Cervical Neoplasms 4Endometrial Neoplasms 4Small Cell Lung Carcinoma 3Recurrence 3Prostatic Neoplasms 3Ovarian Neoplasms 3Neoplasms 3Melanoma 3Febrile Neutropenia 3Waldenstrom Macroglobulinemia 2Venous Thromboembolism 2Skin Neoplasms 2Pancreatic Neoplasms 2Pancreatic Cancer Non-resectable 2Obesity 2Neoplasm Metastasis 2Lymphoma, B-Cell 2Lung Neoplasms 2Leukemia, Lymphocytic, Chronic, B-Cell 2Hepatitis B 2Hematologic Neoplasms 2Gastric / Gastroesophageal Junction Adenocarcinoma 2Carcinoma, Non-Small-Cell Lung 2Biliary Tract Neoplasms 2Anemia 2

Interventions

Levobupivacaine 1Dexmedetomidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Not yet recruiting × Abdominal Cancer Surgery × Clear all
NCT06695468 2024-11-19

Efficacy and Safety of Adding Dexmedetomidine to Levobupivacaine in Rectus Sheath Block Compared to Quadratus Lumborum Block in Patients Undergoing Lower Abdominal Cancer Surgery: A Randomized Clinical Trial

Assiut University

Phase 4 Not yet recruiting
122 enrolled

Abdominal Cancer Surgery

Data powered by HemOnc (CC BY 4.0) Colophon âš¡